Study of antibacterial activity of pharmaceuticals for systemic use

  • In vitro models:
    • assessment of drug interactions with Toll like-receptor of 1/2, 2/6, 4 and 5 types;
    • assessment of multiresistance;
    • assessment of minimal inhibitory (MIC) and minimal bactericide concentration (MBC);
    • assessment of formation speed of microbial resistance to new compounds;
    • identification of targets and investigation of mechanisms of compounds having antibacterial activity.